Hematology · 2021 · 15 citations · 9 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDrug Utilization ReviewImmunopharmacologyPharmacoepidemiologyTreatment EffectivenessDiscrete Choice Experiment DesignDiscrete Choice ModellingEliciting Patient PreferencesFood - Drug InteractionsHealthcare Utilization MeasurementMedication Preference AssessmentThrombopoietin Receptor AgonistsTreatment Choice Preferences
OBJECTIVES: To establish the experiences with and preferences towards existing thrombopoietin-receptor agonist (TPO-RA) treatments of individuals with immune thrombocytopenia (ITP) in the UK and Ireland, based on treatment attributes. METHODS: Responses from UK and Ireland individuals with ITP were collected in a pan-European online survey (TRAPeze, [Thrombopoietin-Receptor Agonist Patient experience survey]) from 18 September 2020 to 18 February 2021. TRAPeze was a survey of treatment preference regarding TPO-RAs (using a discrete choice experiment design), participant demographics, disease characteristics, treatment history, overall satisfaction with therapy, direct healthcare resource utilization and wider social impact. RESULTS: The survey was completed by 32 UK respondents. Characteristics with the greatest influence on preference towards TPO-RA treatments were method of administration (odds ratio (OR) 5.6, 95% confidence interval (CI) 3.2-10.1) and drug-food interactions (OR 3.2, 95% CI 1.8-5.7). Particularly, participants were more likely to select an oral tablet over a subcutaneous injection (OR 7.4, 95% CI 3.6-15.1) and a treatment without food restrictions rather than with food restrictions (OR 3.6, 95% CI 1.8-6.8). CONCLUSION: This is the first study to quantify the preference of individuals with ITP towards TPO-RA treatment attributes and demonstrates preference for orally administered treatments, without drug-food interactions.
9
Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al. · Blood · 2008 · 2.7K citations · Full text
Medicine, Hematology, Immunology +15
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold et al. · Blood Advances · 2019 · 1.3K citations · Full text
Nichola Cooper, Alexandra Kruse, Caroline Kruse et al. · American Journal of Hematology · 2020 · 106 citations · Full text